Impact of pulsed field ablation on intraluminal esophageal temperature

Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural s...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular electrophysiology Vol. 35; no. 1; pp. 78 - 85
Main Authors Kirstein, Bettina, Heeger, Christian‐H., Vogler, Julia, Eitel, Charlotte, Feher, Marcel, Phan, Huong‐Lan, Mushfiq, Ilias, Traub, Anna, Hatahet, Sascha, Samara, Omar, Subin, Behnam, Kuck, Karl‐Heinz, Tilz, Roland R.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated. Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA DS Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe. Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up. A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated.
AbstractList Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated. Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA DS Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe. Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up. A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated.
IntroductionAtrio‐esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose‐dependent esophageal temperature rise has been reported. In the TESO‐PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.MethodsConsecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2DS2Vasc Score 2) underwent first‐time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12‐pole temperature probe.ResultsMedian TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio‐esophageal fistula was reported on follow‐up.ConclusionA small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated.
Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.INTRODUCTIONAtrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2 DS2 Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe.METHODSConsecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2 DS2 Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe.Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up.RESULTSMedian TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up.A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated.CONCLUSIONA small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated.
Author Hatahet, Sascha
Heeger, Christian‐H.
Feher, Marcel
Kirstein, Bettina
Samara, Omar
Tilz, Roland R.
Traub, Anna
Subin, Behnam
Kuck, Karl‐Heinz
Phan, Huong‐Lan
Mushfiq, Ilias
Eitel, Charlotte
Vogler, Julia
Author_xml – sequence: 1
  givenname: Bettina
  orcidid: 0000-0002-6881-871X
  surname: Kirstein
  fullname: Kirstein, Bettina
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 2
  givenname: Christian‐H.
  surname: Heeger
  fullname: Heeger, Christian‐H.
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany, German Center for Cardiovascular Research (DZHK) Partner Site Lübeck Lübeck Germany
– sequence: 3
  givenname: Julia
  orcidid: 0000-0002-8386-9750
  surname: Vogler
  fullname: Vogler, Julia
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 4
  givenname: Charlotte
  surname: Eitel
  fullname: Eitel, Charlotte
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 5
  givenname: Marcel
  surname: Feher
  fullname: Feher, Marcel
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 6
  givenname: Huong‐Lan
  orcidid: 0000-0002-6867-914X
  surname: Phan
  fullname: Phan, Huong‐Lan
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 7
  givenname: Ilias
  surname: Mushfiq
  fullname: Mushfiq, Ilias
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 8
  givenname: Anna
  surname: Traub
  fullname: Traub, Anna
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 9
  givenname: Sascha
  surname: Hatahet
  fullname: Hatahet, Sascha
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 10
  givenname: Omar
  surname: Samara
  fullname: Samara, Omar
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 11
  givenname: Behnam
  orcidid: 0000-0002-4997-9841
  surname: Subin
  fullname: Subin, Behnam
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 12
  givenname: Karl‐Heinz
  surname: Kuck
  fullname: Kuck, Karl‐Heinz
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany
– sequence: 13
  givenname: Roland R.
  orcidid: 0000-0002-0122-7130
  surname: Tilz
  fullname: Tilz, Roland R.
  organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany, German Center for Cardiovascular Research (DZHK) Partner Site Lübeck Lübeck Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37942843$$D View this record in MEDLINE/PubMed
BookMark eNpt0E1LwzAYwPEginvRg19ACl700C1psjQ5ynA6GHjRc3maPtWOtqlJe_Dbm73oYRgCeQ6_BPKfkPPWtkjIDaMzFtZ8a3DGJNXyjIzZQtBYMZmeh5mKRcxVykdk4v2WUsYlXVySEU-1SJTgY7JaNx2YPrJl1A21xyIqK6yLCPIa-sq2UdhV2zuoh6ZqoY7Q2-4TPjCMPTYdOugHh1fkooRw_fp4Tsn76ult-RJvXp_Xy8dNbLhQfZwKjcBNARQMlakEJWUpOS9kDnmSJ1oZnkiWKmEKUVJIOKI2aYECFgnjgk_J_eHdztmvAX2fNZU3WNfQoh18liilKBdC60DvTujWDi58ISjNmNQ6TXbq9qiGvMEi61zVgPvOfgsF8HAAxlnvHZZ_hNFsVz8L9bN9_WDnJ9ZU_T5jCFjV_9z4AX9zheg
CitedBy_id crossref_primary_10_3390_jcm14062071
crossref_primary_10_1111_jce_16127
crossref_primary_10_3390_jcm13102980
crossref_primary_10_1007_s12170_024_00742_9
crossref_primary_10_1016_j_hroo_2024_08_002
crossref_primary_10_1111_jce_16454
crossref_primary_10_1080_17434440_2024_2447809
crossref_primary_10_1016_j_hroo_2024_05_002
crossref_primary_10_3390_jcm13175191
crossref_primary_10_1007_s00399_025_01071_z
crossref_primary_10_1093_europace_euae134
crossref_primary_10_1093_europace_euaf035
Cites_doi 10.1016/j.jacep.2021.02.014
10.1016/j.hrthm.2013.08.012
10.3389/fcvm.2023.1217745
10.1093/europace/euab090
10.1002/pros.22913
10.1161/CIRCEP.119.007781
10.1016/j.ijcha.2020.100576
10.1016/j.jacc.2019.04.021
10.1067/mtc.2001.118041
10.1007/s10439-005-8981-8
10.1111/jce.14980
10.1080/02656736.2020.1753828
10.1161/CIRCEP.119.008303
10.1093/europace/euac033
10.1007/978-3-642-05420-4_5
10.1161/CIRCEP.121.010168
10.1016/j.jacep.2018.04.005
10.1161/CIRCEP.120.008817
10.1007/s12181-017-0179-4
10.1093/eurheartj/ehaa612
10.1161/CIRCEP.116.004672
10.3389/fbioe.2020.552357
ContentType Journal Article
Copyright 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
NPM
7QP
K9.
7X8
DOI 10.1111/jce.16096
DatabaseName CrossRef
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Biology
EISSN 1540-8167
EndPage 85
ExternalDocumentID 37942843
10_1111_jce_16096
Genre Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
04C
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAYXX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACDOS
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOJX
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMSDO
BMXJE
BPMNR
BROTX
BRXPI
BY8
C45
CAG
CITATION
COF
CS3
D-6
D-7
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
ECF
ECT
ECV
EIHBH
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
VVN
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQ9
WQJ
WVDHM
WXI
WXSBR
XG1
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
7QP
K9.
7X8
ID FETCH-LOGICAL-c348t-749ea3cda0ac0676a866f633d6bab2b298c3261784cd4f0a23ee9c7de4a521343
ISSN 1045-3873
1540-8167
IngestDate Fri Jul 11 01:40:13 EDT 2025
Tue Aug 12 12:41:50 EDT 2025
Mon Jul 21 05:56:07 EDT 2025
Thu Apr 24 22:58:54 EDT 2025
Tue Jul 01 01:54:23 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords atrial fibrillation
pulsed field ablation
esophageal temperature
esophageal thermal injury
Language English
License 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c348t-749ea3cda0ac0676a866f633d6bab2b298c3261784cd4f0a23ee9c7de4a521343
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6881-871X
0000-0002-8386-9750
0000-0002-6867-914X
0000-0002-0122-7130
0000-0002-4997-9841
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.16096
PMID 37942843
PQID 2911699729
PQPubID 1086397
PageCount 8
ParticipantIDs proquest_miscellaneous_2888034499
proquest_journals_2911699729
pubmed_primary_37942843
crossref_primary_10_1111_jce_16096
crossref_citationtrail_10_1111_jce_16096
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-00
2024-Jan
20240101
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cardiovascular electrophysiology
PublicationTitleAlternate J Cardiovasc Electrophysiol
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_3_1
Dewhirst MW (e_1_2_8_19_1) 2003; 4954
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
Hong J (e_1_2_8_24_1) 2009; 2009
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
References_xml – ident: e_1_2_8_25_1
  doi: 10.1016/j.jacep.2021.02.014
– ident: e_1_2_8_20_1
  doi: 10.1016/j.hrthm.2013.08.012
– ident: e_1_2_8_17_1
  doi: 10.3389/fcvm.2023.1217745
– ident: e_1_2_8_26_1
  doi: 10.1093/europace/euab090
– ident: e_1_2_8_5_1
  doi: 10.1002/pros.22913
– ident: e_1_2_8_12_1
  doi: 10.1161/CIRCEP.119.007781
– ident: e_1_2_8_18_1
  doi: 10.1016/j.ijcha.2020.100576
– ident: e_1_2_8_14_1
  doi: 10.1016/j.jacc.2019.04.021
– ident: e_1_2_8_3_1
  doi: 10.1067/mtc.2001.118041
– ident: e_1_2_8_6_1
  doi: 10.1007/s10439-005-8981-8
– ident: e_1_2_8_10_1
  doi: 10.1111/jce.14980
– ident: e_1_2_8_21_1
  doi: 10.1080/02656736.2020.1753828
– ident: e_1_2_8_13_1
  doi: 10.1161/CIRCEP.119.008303
– ident: e_1_2_8_22_1
  doi: 10.1093/europace/euac033
– ident: e_1_2_8_7_1
  doi: 10.1007/978-3-642-05420-4_5
– ident: e_1_2_8_15_1
  doi: 10.1161/CIRCEP.121.010168
– volume: 4954
  start-page: 37
  year: 2003
  ident: e_1_2_8_19_1
  article-title: Thermal dose requirement for tissue effect: experimental and clinical findings
  publication-title: Proc SPIE Int Soc Opt Eng
– ident: e_1_2_8_11_1
  doi: 10.1016/j.jacep.2018.04.005
– ident: e_1_2_8_4_1
  doi: 10.1161/CIRCEP.120.008817
– ident: e_1_2_8_16_1
  doi: 10.1007/s12181-017-0179-4
– volume: 2009
  start-page: 3381
  year: 2009
  ident: e_1_2_8_24_1
  article-title: Cardiacablation via electroporation
  publication-title: Conf Proc IEEE Eng Med Biol Soc
– ident: e_1_2_8_2_1
  doi: 10.1093/eurheartj/ehaa612
– ident: e_1_2_8_23_1
– ident: e_1_2_8_8_1
  doi: 10.1161/CIRCEP.116.004672
– ident: e_1_2_8_9_1
  doi: 10.3389/fbioe.2020.552357
SSID ssj0013605
Score 2.5100162
Snippet Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation...
IntroductionAtrio‐esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 78
SubjectTerms Ablation
Electroporation
Esophagus
Fistula
Fistulae
Statistical analysis
Thermal injury
Title Impact of pulsed field ablation on intraluminal esophageal temperature
URI https://www.ncbi.nlm.nih.gov/pubmed/37942843
https://www.proquest.com/docview/2911699729
https://www.proquest.com/docview/2888034499
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKJtBe0Nj4GGzIIISQpkxZ7KTxYztaFdgGDy3qW3RxnIHUJRMkD_CH8PfuHDtOi7rxIVWRlbpO5fv57uz87o6QV1lfCFw14CFWAo9nPveEkKEO8MlyHvbR4uto5LPzaDLj7-fhvNf7tcRaqqv0SP5cG1fyP1LFeyhXHSX7D5J1g-INbKN88YoSxutfyfidC3G8qtHEZYcNH-0Q0oV1BDWNUR9l1KZ0l9I1C1CBaIK5Qn_Z5FO-wT-Vq0xVWy-nOQlZOYr_8BUdSFsyc6g0jboj_3yxKsRRKiZo59RFxwj-XF7YUEQdqO1-OEJHeOHYAGXLRrKnEwH_7XTizzpwSfeid6lT_Rp9p6w-5r4XH5uKHa3CNvlNVoBptK8pBtTa8fA2CyGVPlcTa7Jwn39MxrPT02Q6mk_vkM0Atx-oPzcHw7fDcfd-ykTcur9sc1Y1HLF26FVP54btS-PGTLfJfStfOjBgekB6qtghu4MCqvLyB31NPzn57pC7w7Z178xSMHbJ2ICOljk1oKMN6GgLOoqfZdDRDnR0CXQPyWw8mp5MPFuMw5OMx5XX50IBkxn4INHDiSCOojxiLItSSIM0ELFkOrt_zGXGcx8CppSQ_UxxCHXWQPaIbBRloZ4QGjI_hlwASKmryoeg8mOOLYhwcyBA7JE37cQl0maq1wVTFonbsUqVNHO8R166rlcmPcu6Tvvt7Cd29X5PArTykY4ax8e9cF-jbtUvzKBQZY19YrRujHOBfR4bqbmnMDRk6Nqxp7cP_oxsdctin2xU32p1gG5slT63mLoGe8iibg
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+pulsed+field+ablation+on+intraluminal+esophageal+temperature&rft.jtitle=Journal+of+cardiovascular+electrophysiology&rft.au=Kirstein%2C+Bettina&rft.au=Christian%E2%80%90H+Heeger&rft.au=Vogler%2C+Julia&rft.au=Eitel%2C+Charlotte&rft.date=2024-01-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1045-3873&rft.eissn=1540-8167&rft.volume=35&rft.issue=1&rft.spage=78&rft.epage=85&rft_id=info:doi/10.1111%2Fjce.16096&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-3873&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-3873&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-3873&client=summon